Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Fetal Pediatr Pathol ; 34(1): 18-20, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25166299

ABSTRACT

Glutathione synthetase deficiency (GSSD) is a rare disorder of glutathione metabolism with varying clinical severity. Patients may present with hemolytic anemia alone or together with acidosis and central nervous system impairment. Diagnosis is made by clinical presentation and detection of elevated concentrations of 5-oxoproline in urine and low glutathione synthetase activity in erythrocytes or cultured skin fibroblasts. The prognosis seems to depend on early diagnosis and treatment. We report a 4 months old Tunisian male infant who presented with severe metabolic acidosis with high anion gap and hemolytic anemia. High level of 5-oxoproline was detected in her urine and diagnosis of GSSD was made. Treatment consists of the correction of acidosis, blood transfusion, and supplementation with antioxidants. He died of severe metabolic acidosis and sepsis at the age of 15 months.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Anemia, Hemolytic/diagnosis , Glutathione Synthase/deficiency , Glutathione Synthase/urine , Pyrrolidonecarboxylic Acid/urine , Acidosis/complications , Amino Acid Metabolism, Inborn Errors/complications , Anemia, Hemolytic/complications , Antioxidants/chemistry , Erythrocytes/enzymology , Fatal Outcome , Fever/complications , Fibroblasts/enzymology , Humans , Infant , Klebsiella Infections/complications , Male , Sepsis/complications , Skin/cytology , Treatment Outcome , Tunisia
2.
Gene ; 529(1): 45-9, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-23954227

ABSTRACT

Tyrosinemia type II, also designated as oculocutaneous tyrosinemia or Richner-Hanhart syndrome (RHS), is a very rare autosomal recessive disorder. In the present study, we report clinical features and molecular genetic investigation of the tyrosine aminotransferase (TAT) gene in two young patients, both born to consanguineous unions between first-degree cousins. These two unrelated families originated from Northern and Southern Tunisia. The clinical diagnosis was based on the observation of several complications related to Richner-Hanhart syndrome: recurrent eye redness, tearing and burning pain, photophobia, bilateral pseudodendritic keratitis, an erythematous and painful focal palmo-plantar hyperkeratosis and a mild delay of mental development. The diagnosis was confirmed by biochemical analysis. Sequencing of the TAT gene revealed the presence of a previously reported missense mutation (c.452G>A, p.Cys151Tyr) in a Tunisian family, and a novel G duplication (c.869dupG, p.Trp291Leufs 6). Early diagnosis of RHS and protein-restricted diet are crucial to reduce the risk and the severity of long-term complications of hypertyrosinemia such as intellectual disability.


Subject(s)
Genes, tat , Mutation, Missense , Tyrosinemias/genetics , Amino Acid Sequence , Child, Preschool , Consanguinity , Diet, Protein-Restricted , Humans , Infant , Keratitis/complications , Keratitis/genetics , Male , Molecular Sequence Data , Pedigree , Protein Conformation , Tunisia , Tyrosine Transaminase/genetics , Tyrosine Transaminase/metabolism , Tyrosinemias/complications , Tyrosinemias/diagnosis
3.
Mol Biol Rep ; 40(7): 4197-202, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23649758

ABSTRACT

Genetic deficiency of the glycogen debranching enzyme causes glycogen storage disease type III, an autosomal recessive inherited disorder. The gene encoding this enzyme is designated as AGL gene. The disease is characterized by fasting hypoglycemia, hepatomegaly, growth retardation, progressive myopathy and cardiomyopathy. In the present study, we present clinical features and molecular characterization of two consanguineous Tunisian siblings suffering from Glycogen storage disease type III. The full coding exons of the AGL gene and their corresponding exon-intron boundaries were amplified for the patients and their parents. Gene sequencing identified a novel single point mutation at the conserved polypyrimidine tract of intron 21 in a homozygous state (IVS21-8A>G). This variant cosegregated with the disease and was absent in 102 control chromosomes. In silico analysis using online resources showed a decreased score of the acceptor splice site of intron 21. RT-PCR analysis of the AGL splicing pattern revealed a 7 bp sequence insertion between exon 21 and exon 22 due to the creation of a new 3' splice site. The predicted mutant enzyme was truncated by the loss of 637 carboxyl-terminal amino acids as a result of premature termination. This novel mutation is the first mutation identified in the region of Bizerte and the tenth AGL mutation identified in Tunisia. Screening for this mutation can improve the genetic counseling and prenatal diagnosis of GSD III.


Subject(s)
Glycogen Debranching Enzyme System/genetics , Glycogen Storage Disease Type III/genetics , Introns , Point Mutation , Consanguinity , DNA Mutational Analysis , Female , Gene Order , Glycogen Storage Disease Type III/metabolism , Humans , Infant , Infant, Newborn , Male , RNA Splice Sites , Siblings , Tunisia
4.
Neuropediatrics ; 44(5): 281-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23564319

ABSTRACT

3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency is a rare autosomal recessive disorder of serine biosynthesis. It is typically characterized by congenital microcephaly, intractable seizures of infantile onset, and severe psychomotor retardation. Diagnosis is suspected on decreased l-serine levels in plasma and cerebrospinal fluid (CSF) and confirmed by genetic study. Early diagnosis in index cases allows supplementation in serine and prevention of fixed lesions. Prenatal diagnosis and genetic counseling allows prevention of secondary cases. We report on the two first unrelated Tunisian families with 3-PGDH deficiency confirmed by biochemical and genetic study. We discuss clinical, biochemical, imaging, electroencephalographic, and therapeutic aspects and review the literature.


Subject(s)
Amino Acid Metabolism, Inborn Errors/genetics , Intellectual Disability/genetics , Microcephaly/genetics , Phosphoglycerate Dehydrogenase/deficiency , Seizures/genetics , Serine/biosynthesis , Amino Acid Metabolism, Inborn Errors/metabolism , Child, Preschool , Female , Humans , Intellectual Disability/metabolism , Male , Microcephaly/metabolism , Phosphoglycerate Dehydrogenase/genetics , Seizures/metabolism , Tunisia
5.
Tunis Med ; 90(3): 258-61, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22481200

ABSTRACT

BACKGROUND: Inborn errors of metabolism are neglected in developing countries because they are not as common as infectious and nutritional disorders. In Tunisia, no information is available on the incidence and epidemiological features of these inherited metabolic diseases. AIMS: To precise the profile of aminoacidopathies other than phenylketonuria and organic acidurias and to estimate their incidences in Tunisia. METHODS: Between 1987 and 2009, our laboratory received 13171 requests for analysis of patients with symptoms suggestive of inborn errors of metabolism. For these cases, ion exchange chromatography of free amino acids was performed on amino acids analyser. Urinary organic acids profiles were determined by gas chromatography-mass spectrometry. RESULTS: Abnormal cases were 370 (2.8%), divided into 212 cases of aminoacidopathies (57.3%) and 158 cases of organic acidurias (42.7%). The most frequent aminoacidopathies, were maple syrup disease (32.5%), tyrosinemia type I (28.8%) and nonketotic hyperglycinemia (16%). Methylmalonic aciduria (33.5%), propionic aciduria (18.4%) and 2-hyrdoxy glutaric aciduria (10.8%) were the most frequent organic acidurias. The incidences were calculated using the Hardy-Weinberg formula and were estimated at 1/13716 for maple syrup disease, 1/14804 for tyrosinemia type I, 1/16144 for methylmalonic aciduria and 1/23176 for propionic aciduria. CONCLUSION: Aminoacidopathies and organic acidurias turned out to be highly frequent in Tunisia, mainly because of a high rate of consanguinity. We believe that they are underestimated. To improve their diagnosis, it is necessary to have available sophisticated equipment which would allow early treatment of patients.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Amino Acid Metabolism, Inborn Errors/epidemiology , Adolescent , Adult , Amino Acid Transport Disorders, Inborn/diagnosis , Amino Acid Transport Disorders, Inborn/epidemiology , Child , Child, Preschool , Data Collection , Female , Gas Chromatography-Mass Spectrometry/methods , Humans , Incidence , Infant , Male , Mass Screening/methods , Retrospective Studies , Time Factors , Tunisia/epidemiology , Young Adult
6.
Tunis Med ; 89(3): 288-91, 2011 Mar.
Article in French | MEDLINE | ID: mdl-21387236

ABSTRACT

BACKGROUND: Zellweger syndrome is the most severe phenotype of the peroxisome biogenesis disorders caused by mutations in PEX genes. PEX 1, 6 and 26 genes are most frequently implicated. Clinical phenotype can't predict the mutated gene. AIM: To report a novel mutation in the PEX 26 gene in infant with typical Zellweger syndrome. CASE REPORT: the infant was the second child to consanguineous parents; the 1st child was dead with neonatal hypotonia. At two month of age, we noted a severe hypotonia and growth failure, characteristic facial dysmorphic features and cryptorchidism. Sensorial investigations showed optic atrophy. Cerebral tomography revealed white matter hypodensity. Radiological examination revealed calcific stippling of the patellas. The clinical diagnosis was supported by measurement of plasma very-long-chain fatty acids, with elevated C24:0/C22:0, C26:0/C22:0 ratios and decreased docosanoic acid peak. The diagnosis was confirmed by dosage of DHAP-AT activity in fibroblasts which was very low. Ultrastructural examinations showed the presence of peroxisomal ghosts. Genetic analysis demonstrated a new mutation in PEX 26 gene.The death occurred at the age of 8 months of refractor epilepsy and apneas. CONCLUSION: The poor prognosis of ZS incites paediatricians to consider this disorder in etiological investigations of precocious hypotonia. Biochemical diagnosis, available in Tunisia, offers opportunity of prenatal diagnosis in affected families.


Subject(s)
Membrane Proteins/genetics , Mutation , Zellweger Syndrome/genetics , Humans , Infant, Newborn , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...